Lucentis (Ranibizumab) for Eales' Disease

NCT00384449 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Eales' Disease

Interventions

DRUG: Ranibizumab

Sponsor

Oregon Health and Science University

Collaborators

[object Object]